Your browser doesn't support javascript.
loading
A phase I/II study of lenalidomide in combination with sunitinib in patients with advanced or metastatic renal cell carcinoma.
Rini, B; Redman, B; Garcia, J A; Burris, H A; Li, S; Fandi, A; Beck, R; Jungnelius, U; Infante, J R.
Afiliación
  • Rini B; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland. Electronic address: rinib2@ccf.org.
  • Redman B; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan, Ann Arbor.
  • Garcia JA; Department of Solid Tumor Oncology, Cleveland Clinic Taussig Cancer Institute, Glickman Urological Institute, Cleveland.
  • Burris HA; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
  • Li S; Celgene Corporation.
  • Fandi A; Celgene Corporation.
  • Beck R; Celgene Corporation.
  • Jungnelius U; Celgene Corporation.
  • Infante JR; Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville.
Ann Oncol ; 25(9): 1794-1799, 2014 Sep.
Article en En | MEDLINE | ID: mdl-24914044

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / Talidomida / Carcinoma de Células Renales / Inhibidores de la Angiogénesis / Indoles / Neoplasias Renales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pirroles / Talidomida / Carcinoma de Células Renales / Inhibidores de la Angiogénesis / Indoles / Neoplasias Renales Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2014 Tipo del documento: Article